Lupin has informed that the Board of Directors of the company at its meeting held on May 07, 2014, has recommended final dividend at the rate of 150% i.e. Rs 3 per equity share of the face value of Rs 2 each for the year ended March 31, 2014 subject to the approval of the shareholders at the ensuing Annual General Meeting. The Board of Directors had at their meeting held on February 03, 2014, declared and paid interim dividend of Rs 3 per equity share of Rs 2 each. Thus, the total dividend for the year ended March 31, 2014 would be Rs 6 per equity share.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1862.70 |
| Dr. Reddys Labs. | 1356.85 |
| Cipla | 1465.15 |
| Zydus Lifesciences | 1112.20 |
| Lupin | 2420.15 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: